ISPOR TASK FORCE REPORT
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
This second Task Force report provides emerging good-practice guidance on the implementation of MCDA to support health care decisions, including: a checklist to support the design, implementation and review of an MCDA; guidance to support the implementation of the checklist, the order in which the steps should be implemented, and incorporating budget constraints into an MCDA; an overview of the skills and resources required to implement MCDA, including the available software; and future research directions.
Challenges in Using MCDA for Reimbursement Decisions on New Medicines?
Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
In this study, Sophie Whyte et al. demonstrate the use of diffusion curves and multi-period analysis to estimate the value of investing in implementation activities to increase uptake of natriuretic peptide testing.
Responsiveness to Change in PROMIS® Measures among Children with Asthma: A Report from the PROMIS® Pediatric Asthma Study
This study by I-Chan Huang et al. aimed to compare the responsiveness to change of the Patient-Reported Outcomes Measurement Information System (PROMIS®) asthma impact, pain interference, fatigue, depressive symptoms, mobility, and peer relationships scales to a legacy scale, the Paediatric Asthma Quality of Life Questionnaire.
Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
In this study, Koonal Kirit et al. assess differences in time-trade-off valuations using two different comparators (full health and 11111).
COMPARATIVE EFFECTIVENESS RESEARCH / HTA
The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan
Eman A. Hammad describes the role of economic evidence in drug pricing decisions in Jordan.
Expanding Health Technology Assessments to Include Effects on the Environment
Kevin Marsh et al. consider the case for incorporating environmental impacts into the health technology assessment process and discuss the associated challenges.
Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review
This review by Michael Herdman et al. investigates how utility weights have been elicited and used in cost-effectiveness analysis of paediatric vaccines for infectious diseases which requires quality-of-life (utility) weights.
Also in this Issue:
Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia
The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index
Comprehensively Measuring Health-Related Subjective Well-Being: Dimensionality Analysis for Improved Outcome Assessment in Health Economics
Improving Adherence to Cardiovascular Therapies: An Economic Evaluation of a Randomized Pragmatic Trial
Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness
Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer
Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales
COMPARATIVE EFFECTIVENESS RESEARCH / HTA
Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States
Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review
Patient-Centered Outcomes of Medication Adherence Interventions: Systematic Review and Meta-Analysis
Systematic Review of Economic Evaluations of Units Dedicated to Acute Coronary Syndromes